Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene

被引：6
|
作者：
Li, Rong [1 ]
Baskfield, Amanda [1 ]
Beers, Jeanette [2 ]
Zou, Jizhong [2 ]
Liu, Chengyu [3 ]
Almeciga-Diaz, Carlos J. [4 ]
Zheng, Wei [1 ]
机构：
[1] NIH, Natl Ctr Advancing Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA
[2] NHLBI, iPSC Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Cra 7 43-82 Lab,305A Edificio 54, Bogota, Colombia
来源：
STEM CELL RESEARCH | 2019年 / 36卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.scr.2019.101408
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Mucopolysaccharidosis type IVA (MPS IVA) is a rare genetic disease caused by mutations in the GALNS gene and is inherited in an autosomal recessive manner. GALNS encodes N-acetylgalactosamine-6-sulfatase that breaks down certain complex carbohydrates known as glycosaminoglycans (GAGs). Deficiency in this enzyme causes accumulation of GAGs in lysosomes of body tissues. A human induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts of a MPS IVA patient that has compound heterozygous mutations (p.R61W and p.WT405del) in the GALNS gene. This iPSC line offers a useful resource to study the disease pathophysiology and a cell-based model for drug development.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene
    Huang, Xiuli
    Roeder, Amanda
    Li, Rong
    Beers, Jeanette
    Liu, Chengyu
    Zou, Jizhong
    Yu, Paul B.
    Zheng, Wei
    STEM CELL RESEARCH, 2021, 54
  • [32] Generation of the induced pluripotent stem cell line (NCKDi002-A) from a 22-year-old patient with Focal Segmental Glomerular Sclerosis carrying a heterozygous mutation in WT1 gene
    Wu, Hangdi
    Wang, Gang
    Gao, Erzhi
    Zhao, Jing
    Zhang, Li
    Chen, Lang
    Zhu, Yuqing
    Zhang, Jin
    Liu, Zhihong
    STEM CELL RESEARCH, 2021, 53
  • [33] Establishment of human induced pluripotent stem cell line SDQLCHi029-A from one Type 1 familial glucocorticoid deficiency patient carrying compound heterozygote mutations in MC2R gene
    Zhang, Haiyan
    Liu, Chen
    Liu, Yi
    Gai, Zhongtao
    STEM CELL RESEARCH, 2024, 76
  • [34] Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene
    Sun, Xiaofang
    Zhou, Xiang
    Xiao, Xinhua
    Chi, Jingwei
    Dong, Bingzi
    Wang, Yangang
    STEM CELL RESEARCH, 2020, 45
  • [35] Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3
    Dementyeva, E. V.
    Pavlova, S. V.
    Chernyavsky, A. M.
    Zakian, S. M.
    STEM CELL RESEARCH, 2021, 53
  • [36] Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene
    Xiao, Cheng
    Yu, Miao
    Liu, Jieying
    Wu, Han
    Deng, Mingqun
    Zhang, Qian
    Xiao, Xinhua
    STEM CELL RESEARCH, 2020, 42
  • [37] Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene
    Kondrateva, Ekaterina
    Demchenko, Anna
    Slesarenko, Yana
    Pozhitnova, Victoria
    Yasinovsky, Matvey
    Amelina, Elena
    Tabakov, Vyacheslav
    Voronina, Ekaterina
    Lavrov, Alexander
    Smirnikhina, Svetlana
    STEM CELL RESEARCH, 2021, 52
  • [38] Generation of a human induced pluripotent stem cell line (UQACi001-A) from a severe epidermolysis bullosa simplex patient with the heterozygous mutation p.R125S in the KRT14 gene
    Bchetnia, Mbarka
    Martineau, Laurie
    Racine, Veronique
    Powell, Julie
    McCuaig, Catherine
    Puymirat, Jack
    Laprise, Catherine
    STEM CELL RESEARCH, 2020, 44
  • [39] Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1
    Brooks, Brianna M.
    Yeh, Charles D.
    Beers, Jeanette
    Liu, Chengyu
    Cheng, Yu-Shan
    Gorshkov, Kirill
    Zou, Jizhong
    Zheng, Wei
    Chen, Catherine Z.
    STEM CELL RESEARCH, 2021, 53
  • [40] Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene
    Marote, Ana
    Pomeshchik, Yuriy
    Goldwurm, Stefano
    Collin, Anna
    Lamas, Nuno J.
    Pinto, Luisa
    Salgado, Antonio J.
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 90 - 94
12345